{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:57:46Z","timestamp":1793959066007,"version":"4.8.0"},"reference-count":19,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Epstein-Barr virus (EBV) is associated with a variety of tumors and nonmalignant conditions. Latent EBV genomes in cells, including tumor cells, are often CpG methylated, whereas virion DNA is not CpG methylated. We demonstrate that methyl CpG binding magnetic beads can be used to fractionate among sources of EBV DNA (DNA extracted from laboratory-purified virions vs DNA extracted from latently infected cell lines). We then applied the technique to plasma specimens and showed that this technique can distinguish EBV DNA from patients with EBV-associated tumors (nasopharyngeal carcinoma, Hodgkin lymphoma) and viral DNA from patients without EBV-associated tumors, including immunocompromised patients and patients with EBV(\u2212) Hodgkin lymphoma.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001511","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T16:00:31Z","timestamp":1587398431000},"page":"1624-1627","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-2852","authenticated-orcid":false,"given":"Meir","family":"Shamay","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;"},{"name":"Daniella Lee Casper Laboratory in Viral Oncology, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kanakry","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;"},{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. W.","family":"Low","sequence":"first","affiliation":[{"name":"Cancer Science Institute of Singapore, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel A.","family":"Horowitz","sequence":"first","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Journo","sequence":"first","affiliation":[{"name":"Daniella Lee Casper Laboratory in Viral Oncology, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Ahuja","sequence":"first","affiliation":[{"name":"Daniella Lee Casper Laboratory in Viral Oncology, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan","family":"Eran","sequence":"first","affiliation":[{"name":"Daniella Lee Casper Laboratory in Viral Oncology, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Barzilai","sequence":"first","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldad J.","family":"Dann","sequence":"first","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel;"},{"name":"Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stone","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Lu","family":"Woo","sequence":"first","affiliation":[{"name":"Cancer Science Institute of Singapore, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-son","family":"Hsieh","sequence":"first","affiliation":[{"name":"Cancer Science Institute of Singapore, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5532-6524","authenticated-orcid":false,"given":"Rena R.","family":"Xian","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;"},{"name":"Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-3073","authenticated-orcid":false,"given":"Richard F.","family":"Ambinder","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"issue":"6378","key":"2020042011382959500_B1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"18","key":"2020042011382959500_B2","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer Treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"2020042011382959500_B3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMe1706815","article-title":"Plasma Epstein-Barr virus DNA for screening","volume":"377","author":"Ambinder","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"2020042011382959500_B4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"2020042011382959500_B5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/annonc\/mdu117","article-title":"Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma","volume":"25","author":"Leung","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"2020042011382959500_B6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cncr.31741","article-title":"Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma","volume":"125","author":"Guo","year":"2019","journal-title":"Cancer"},{"issue":"18","key":"2020042011382959500_B7","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","article-title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","volume":"121","author":"Kanakry","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2020042011382959500_B8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/bloodadvances.2016002618","article-title":"Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma","volume":"1","author":"Welch","year":"2017","journal-title":"Blood Adv"},{"issue":"16","key":"2020042011382959500_B9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2020042011382959500_B10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.0.CO;2-J","article-title":"Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin\u2019s disease","volume":"84","author":"Gallagher","year":"1999","journal-title":"Int J Cancer"},{"issue":"4","key":"2020042011382959500_B11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V91.4.1373","article-title":"Epstein-Barr virus (EBV) in endemic Burkitt\u2019s lymphoma: molecular analysis of primary tumor tissue","volume":"91","author":"Tao","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2020042011382959500_B12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0002-9440(10)65157-7","article-title":"Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis","volume":"155","author":"Tao","year":"1999","journal-title":"Am J Pathol"},{"issue":"13","key":"2020042011382959500_B13","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood.V96.13.4055","article-title":"Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response","volume":"96","author":"Yang","year":"2000","journal-title":"Blood"},{"issue":"9","key":"2020042011382959500_B14","doi-asserted-by":"crossref","first-page":"e1001114","DOI":"10.1371\/journal.ppat.1001114","article-title":"CpG-methylation regulates a class of Epstein-Barr virus promoters","volume":"6","author":"Bergbauer","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6","key":"2020042011382959500_B15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2217\/fmb.14.41","article-title":"Role of epigenetics in EBV regulation and pathogenesis","volume":"9","author":"Niller","year":"2014","journal-title":"Future Microbiol"},{"key":"2020042011382959500_B16","doi-asserted-by":"crossref","article-title":"Coordinate Regulation of TET2 and EBNA2 Control DNA Methylation State of Latent Epstein-Barr Virus","author":"Lu","DOI":"10.1128\/JVI.00804-17"},{"issue":"2","key":"2020042011382959500_B17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1309\/MMAU-0QYH-7BHA-W8C2","article-title":"Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma","volume":"117","author":"Gulley","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2020042011382959500_B18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jcp.2003.013094","article-title":"Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel","volume":"57","author":"Bar-Sela","year":"2004","journal-title":"J Clin Pathol"},{"issue":"1","key":"2020042011382959500_B19","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41467-019-11226-5","article-title":"Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases","volume":"10","author":"Lam","year":"2019","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2020002179","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/8\/1624\/1724590\/advancesadv2020001511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/8\/1624\/1724590\/advancesadv2020001511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T16:01:05Z","timestamp":1587398465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/8\/1624\/454412\/CpG-methylation-in-cellfree-EpsteinBarr-virus-DNA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001511","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/bloodadvances.2020002179","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}